Meriwether Wealth & Planning’s Alnylam Pharmaceuticals ALNY Stock Holding History

Meriwether Wealth & Planning’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.64K	Buy	+35	New	+$8.91K	﹤0.01%	443

Other funds holding ALNY

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Meriwether Wealth & Planning's ALNY Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 35 shares worth $8.64K. The stake represents ﹤0.01% of the portfolio and ranks #443 among its holdings.

174 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

Meriwether Wealth & Planning held 35 shares of Alnylam Pharmaceuticals worth $8.64K as of Q3 2026.
Alnylam Pharmaceuticals was a new Meriwether Wealth & Planning position in Q3 2026.
Alnylam Pharmaceuticals made up ﹤0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #443 holding.
174 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.